MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv... MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. Show more
International Business Machines (NYSE:IBM) – According to the South China Morning Post, IBM has closed its R&D operations in China, laying off over 1,000 employees due to geopolitical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2 | -15.3846153846 | 1.3 | 1.315 | 1.05 | 515756 | 1.13797746 | CS |
4 | -0.86 | -43.8775510204 | 1.96 | 1.98 | 1.05 | 655114 | 1.45385641 | CS |
12 | 0.48 | 77.4193548387 | 0.62 | 5.01 | 0.51 | 5947825 | 3.38950052 | CS |
26 | -0.12 | -9.83606557377 | 1.22 | 5.01 | 0.51 | 2777933 | 3.33371742 | CS |
52 | -3.5 | -76.0869565217 | 4.6 | 6.4 | 0.51 | 1624766 | 3.12680385 | CS |
156 | -5.9 | -84.2857142857 | 7 | 7.9799 | 0.51 | 1440593 | 3.15452392 | CS |
260 | -5.9 | -84.2857142857 | 7 | 7.9799 | 0.51 | 1440593 | 3.15452392 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.